A case of lung adenocarcinoma harboring EGFR mutation and EML4-ALK fusion gene

BACKGROUND: Lung cancer is the leading cause of cancer-related death worldwide. Epidermal growth factor receptor (EGFR) - tyrosine kinase inhibitor (TKI) is used for the patients with EGFR-mutant lung cancer. Recently, phase III studies in the patients with EGFR-mutant demonstrated that EGFR-TKI mon...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Tanaka, Hisashi, Hayashi, Akihito, Morimoto, Takeshi, Taima, Kageaki, Tanaka, Yoshihito, Shimada, Michiko, Kurose, Akira, Takanashi, Shingo, Okumura, Ken
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2012
Teme:
Case Report
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3515412/
https://ncbi.nlm.nih.gov/pubmed/23181703
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-12-558
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki